ACE2, From the Kidney to SARS-CoV-2: Donald Seldin Award Lecture 2023

Daniel Batlle1, Luise Hassler1, Jan Wysocki1

  • 1Division of Nephrology/Hypertension, Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL.

PubMed
Summary

Soluble angiotensin-converting enzyme 2 (ACE2) proteins offer dual therapeutic potential by targeting the kidney renin-angiotensin system and neutralizing SARS-CoV-2. Bioengineered soluble ACE2 provides protection against SARS-CoV-2 variants.